U.S., Oct. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07883642) titled 'Traditional Chinese Medicine Treatment for Capecitabine-Related Hand-Foot Syndrome' on Oct. 11.
Brief Summary: This study is a prospective, single-center, randomized, parallel-group, open-label clinical trial titled "Intervention with the 'Xu Xue Tong Luo Traditional Chinese Medicine Compound for Capecitabine-Related Hand-Foot Syndrome." The research hypothesis is that adding this traditional Chinese medicine hand and foot bath to standard baseline care will result in a significantly higher efficacy rate-defined as a >=1-grade reduction in Hand-Foot Syndrome (HFS) severity after 3 weeks-compared to baseline care alone.The study plan...